Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Jan Westerink"'
Autor:
Bram E. L. Vrijsen, Saskia Haitjema, Jan Westerink, Cornelia A. R. Hulsbergen-Veelken, Wouter W. van Solinge, Maarten J. ten Berg
Publikováno v:
BMC Emergency Medicine, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background A longer emergency department length of stay (EDLOS) is associated with poor outcomes. Shortening EDLOS is difficult, due to its multifactorial nature. A potential way to improve EDLOS is through shorter turnaround times for diagn
Externí odkaz:
https://doaj.org/article/aefaeb35f7e24d92bfd0a3ecac48f16f
Autor:
Dian Sidik Arsyad, Esliana Fitrida Hamsyah, Nurul Qalby, Andriany Qanitha, Jan Westerink, Maarten J. Cramer, Frank L. J. Visseren, Pieter A. Doevendans, Ansariadi Ansariadi
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Backgrounds The increasing burden of cardiovascular disease (CVD) has become a major challenge globally, including in Indonesia. Understanding the readiness of primary health care facilities is necessary to confront the challenge of providin
Externí odkaz:
https://doaj.org/article/9a1cb4887c174758aa56f8541e074693
Autor:
Femke V. M. Mulder, Evelien F. H. I. Peeters, Jan Westerink, Fried J. T. Zwartkruis, Wendela L. de Ranitz-Greven
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background MTOR inhibition is an effective treatment for many manifestations of tuberous sclerosis complex. Because mTOR inhibition is a disease modifying therapy, lifelong use will most likely be necessary. This study addresses the long-ter
Externí odkaz:
https://doaj.org/article/c90b1abef9fe4f0994da3c5b1a92569a
Autor:
Dian Sidik Arsyad, Jan Westerink, Maarten J. Cramer, Jumriani Ansar, Wahiduddin, Frank L. J. Visseren, Pieter A. Doevendans, Ansariadi
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Backgrounds The majority of risk factors for cardiovascular diseases (CVDs) are modifiable. Continuous monitoring and control of these factors could significantly reduce the risk of CVDs-related morbidity and mortality. This study estimated
Externí odkaz:
https://doaj.org/article/ccc3aaddbd2f4978b0c86ef803dd30d8
Autor:
Michiel L Bots, N Charlotte Onland-Moret, Pim A de Jong, L Jaap Kappelle, Frank L J Visseren, Folkert W Asselbergs, Ynte M Ruigrok, Steven H J Hageman, Jan Westerink, Maarten van Smeden, Gert J de Borst, Maarten J Cramer, Jannick A N Dorresteijn, Marianne C Verhaar, Mirjam I Geerlings, Maria C Castelijns, Marga A G Helmink, Marielle H Emmelot-Vonk, Niels P van der Kaaij, A Titia Lely, Manon G van der Meer, Barend M Mol, Hendrik M Nathoe, Rutger B van Petersen, Martin Teraa, Angela Vandersteen
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Purpose The Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study is an ongoing prospective single-centre cohort study with the aim to assess important determinants and the prognosis of cardiovascular disease pro
Externí odkaz:
https://doaj.org/article/362168b1522e47a89038140cb39605ae
Autor:
Robert J. C. M. F. de Kleijn, Ludo Schropp, Jan Westerink, Eline S. van Hattum, Bart-Jeroen Petri, Gert J. de Borst
Publikováno v:
Frontiers in Surgery, Vol 9 (2023)
IntroductionThe low prevalence of Arterial Thoracic Outlet Syndrome (ATOS) and diffuse symptomatology have resulted in limited data on optimal treatment strategies and long-term outcome. The aim of this study was to report and evaluate a single cente
Externí odkaz:
https://doaj.org/article/3b1f22d3c4784bebb7cf0737615c482a
Autor:
Ludo Schropp, Robert J C M F de Kleijn, Jan Westerink, Mathilde Nijkeuter, Evert-Jan Vonken, Irene C van der Schaaf, H Stephan Goedee, Alexander F J E Vrancken, Eline S van Hattum, Bart-Jeroen Petri, Gert J de Borst, TROTS registry collaborators
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0279708 (2023)
IntroductionThere is a lack of comprehensive and uniform data on primary upper extremity deep venous thrombosis (pUEDVT). pUEDVT includes venous thoracic outlet syndrome related upper extremity deep venous thrombosis (UEDVT) and idiopathic UEDVT. Res
Externí odkaz:
https://doaj.org/article/e98a670ab7e74c6bbb123af57c14a7b2
Autor:
Shahnam Sharif, Y. Van der Graaf, M. J. Cramer, L. J. Kapelle, G. J. de Borst, Frank L. J. Visseren, Jan Westerink, the SMART study group
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-8 (2021)
Abstract Background Type 2 diabetes is a condition associated with a state of low-grade inflammation caused by adipose tissue dysfunction and insulin resistance. High sensitive-CRP (hs-CRP) is a marker for systemic low-grade inflammation and higher p
Externí odkaz:
https://doaj.org/article/d111bce3c9f04bb99a2b41879fa13076
Autor:
Lisanne C. A. Smidt, Frank L. J. Visseren, Wendela L. de Ranitz-Greven, Hendrik M. Nathoe, L. Jaap Kappelle, Gert J. de Borst, Harold W. de Valk, Jan Westerink, the UCC-SMART Study Group
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Background Recent treatment guidelines support the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes and cardiovascular disease based on the results of cardiovascular outcome trials (CVOTs). Applicabi
Externí odkaz:
https://doaj.org/article/f3a9a7dde06648ed9979c46353fab63c
Publikováno v:
BJGP Open, Vol 6, Iss 1 (2022)
Background: Inappropriately repeated laboratory testing is a commonly occurring problem. However, this has not been studied extensively in the outpatient clinic after referral by GPs. Aim: The aim of this study was to investigate how often laboratory
Externí odkaz:
https://doaj.org/article/8d5c34c5e51844c68bea61d1553d2b9d